Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Grace Therapeutics, Inc. is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, and reduced side effects. Its lead clinical asset, GTx-104, is an intravenous infusion targeting aneurysmal Subarachnoid Hemorrhage (aSAH), a rare and life-threatening medical emergency in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull. The nanoparticle technology of GTx-104 facilitates aqueous formulation of insoluble nimodipine for a standard peripheral IV infusion. Its other pipeline includes GTX-102, which is targeted as the first potential therapy for the treatment of ataxia-telangiectasia (AT) in a pediatric population and GTx-101, which is a topical administration via a bioadhesive, film-forming polymer, for the treatment of pain associated with postherpetic neuralgia.
Find out what a historical investment in Grace Therapeutics Inc would be worth today using our GRCE stock calculator.
Buying GRCE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Grace Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in GRCE
What is the ticker symbol of Grace Therapeutics Inc?
The ticker symbol for Grace Therapeutics Inc is GRCE.
How much is one share of GRCE?
One share of GRCE is valued at $1.73 as of 20 November 2026.
What is the market capitalisation of Grace Therapeutics Inc GRCE?
As of 20 November 2026 Grace Therapeutics Inc has a market cap of $36.39M.
What is the 52-week high for Grace Therapeutics Inc stock?
The Grace Therapeutics Inc 52-week high stock price is $5.18.
What is the 52-week low for Grace Therapeutics Inc stock?
The Grace Therapeutics Inc 52-week low stock price is $1.64.
Can I buy GRCE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GRCE shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GRCE on Stake
Buy GRCE from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of GRCE from only US$10 with fractional shares